Xuebijing as a potential therapeutic option for septic shock: the need for rigorous evaluation of life-threatening adverse effects. [PDF]
Crit CareHonoré PM +5 more
europepmc +1 more source
The Progress of Xuebijing Injection in Clinical Application
Advances in Clinical Medicine, 2018 openaire +1 more source
Correction: Bijelić et al. Phytochemicals in the Prevention and Treatment of SARS-CoV-2-Clinical Evidence. <i>Antibiotics</i> 2022, <i>11</i>, 1614. [PDF]
Antibiotics (Basel)Bijelić K, Hitl M, Kladar N.
europepmc +1 more source
Advancing traditional Chinese medicine for sepsis-challenges beyond clinical evidence. [PDF]
Crit CareHuang W, Wang M.
europepmc +1 more source
A critically ill adolescent with EBV-associated hemophagocytic lymphohistiocytosis-induced hyperinflammatory shock: a case report and literature review. [PDF]
Front ImmunolChen Y, Zhang R, Wang C, Ren Y.
europepmc +1 more source
Background: Xuebijing (XBJ) is widely applied in the treatment of Acute Lung Injury (ALI). This study focused on the potential mechanism of XBJ in Lipopolysaccharide (LPS)-induced ALI. Methods: The rat ALI model was established by injection of LPS (10 mg/
Wu, XiaoYong +6 more
core
Clinical efficacy and mechanistic insights of Xuebijing in hand, foot, and mouth disease: a meta-analysis with integrated pharmacological approaches. [PDF]
Ann Med Surg (Lond)Li J +9 more
europepmc +1 more source
Traditional Chinese medicine for sepsis: advancing from evidence to innovative drug discovery. [PDF]
Crit CareJi Y, Song H, Li L.
europepmc +1 more source
Editorial: Natural products in the fight against antibiotic resistance: addressing the WHO priority pathogens. [PDF]
Front PharmacolDhanani T +3 more
europepmc +1 more source
Efficacy of Xuebijing injection on pulmonary ventilation improvement in acute pancreatitis: a systematic review and meta-analysis. [PDF]
Front PharmacolBin Y, Peng R, Lee Y, Lee Z, Liu Y.
europepmc +1 more source